This Week at FDA: Agency won’t extend LDT rule comment period, drops new guidances, and schedules meetings
This Week at FDAFerdous Al-Faruque
Advanced therapies/cell and gene therapyAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIGenericsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyUnited States